Drug Master Files for: morphine sulfate
✉ Email this page to a colleague
morphine sulfate Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 11529 | I | II | 7/6/1995 | MALLINCKRODT INC | MORPHINE SULFATE INJECTION USP |
| 12808 | I | II | 12/23/1997 | ELAN PHARMA LTD | MORPHINE SULFATE |
| 12818 | A | II | 1/7/1998 | SANOFI CHIMIE | APOMORPHINE HYDROCHLORIDE |
| 13188 | A | II | 9/11/1998 | MACFARLAN SMITH LTD | APOMORPHINE HYDROCHLORIDE |
| 14641 | I | II | 12/23/1999 | ARADIGM CORP | AERX MORPHINE SULFATE PAIN MANAGEMENT SYSTEM |
| 16433 | I | II | 2/21/2003 | ALKERMES INC | AVINZA((R) (MORPHINE SULFATE EXTENDED-RELEASE CAPSULES) 30MG, 45MG, 60MG, 75MG, 90MG AND 120MG |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
